Neuroscientific to Acquire Leading Stem Cell Technology

Development and stem cells seminar

Development and stem cells seminar | Takashi Hiragi olearyj 16 April 2025 15:30 16:30 Interested in attending? Details on how to join are sent out through the interest group mailing list before each seminar. Visit the interest group's page to find out more, or contact DSC-admin@crick.ac.uk to join the mailing list. This is part of our Development and Stem Cells Interest Group seminar series Speaker: Takashi Hiragi, Hubrecht Institute, Netherlan…

Neuroscientific to Acquire Leading Stem Cell Technology

NeuroScientific Biopharmaceuticals Ltd (ASX:NSB) to acquire StemSmartTM patented Stem Cell technology (StemSmart), for the manufacture of life-changing cellular medicine, Mesenchymal Stromal Cells (MSC), from Isopogen WA Ltd (Isopogen WA). About StemSmart AcquisitionEarly indications from the Phase 2 trial in refractory Crohn’s disease suggest StemSmartTM MSC is potent, efficacious and safe (refer to Annexure 1 for a summary of the details and f…